Cite
HARVARD Citation
Kutschera, M. et al. (n.d.). DOP74 Initial Clearance of infliximab is a predictor for the time of formation of anti-drug antibodies. Journal of Crohn's and colitis. pp. S108-S109. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kutschera, M. et al. (n.d.). DOP74 Initial Clearance of infliximab is a predictor for the time of formation of anti-drug antibodies. Journal of Crohn's and colitis. pp. S108-S109. [Online].